Q2 2015

Filed Aug 10, 2015 · 10-Q · 41 days after period end · 0001144204-15-047830

Q2 2015 · 10-Q

Revenue

$391.00K

— vs Q2 2014

Net Income

-$66.85M

N/M vs Q2 2014

EPS Diluted

-$0.88

N/M vs Q2 2014

Operating Income-$38,854,000N/M

Operating Cash Flow

Same quarter

Metric	Q2 2015	Q2 2014	Q2 2013	Q2 2012
Revenue	$391.00K	$0.00	$272.00K	$330.00K
Net Income	-$66.85M	-$25.87M	-$11.59M	-$10.15M
EPS Diluted	-$0.88	-$0.45	-$0.40	-$0.06

The same fiscal quarter, prior years. Thaler holds no estimates to compare against.

Northwest Biotherapeutics Inc · CIK 1072379 · Engraved from SEC EDGAR